Koesten Hirschmann & Crabtree’s Medtronic MDT Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$134	–	155
2025 Q3	$134	Sell	1 -45	-98%	-$4.14K	﹤0.01%	243
2025 Q2	$4.01K	Buy	46 +45	+4,500%	+$3.82K	﹤0.01%	191
2025 Q1	$127	Hold	1	–	–	﹤0.01%	203
2024 Q4	$113	Hold	1	–	–	﹤0.01%	193
2024 Q3	$127	Hold	1	–	–	﹤0.01%	192
2024 Q2	$123	Hold	1	–	–	﹤0.01%	213
2024 Q1	$123	Hold	1	–	–	﹤0.01%	213
2023 Q4	$116	Hold	1	–	–	﹤0.01%	178
2023 Q3	$111	Hold	1	–	–	﹤0.01%	173
2023 Q2	$124	Hold	1	–	–	﹤0.01%	161
2023 Q1	$114	Hold	1	–	–	﹤0.01%	247
2022 Q4	$109	Buy	+1	New	+$81	﹤0.01%	157

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Koesten Hirschmann & Crabtree's MDT Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of Medtronic (MDT) in Q4 2025, closing a stake of 1 share — an estimated $134 sold.

Koesten Hirschmann & Crabtree first reported a position in MDT in Q4 2022 and held it in 12 quarters. The position peaked at $4.01K in Q2 2025. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

Koesten Hirschmann & Crabtree reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
Koesten Hirschmann & Crabtree sold 1 Medtronic share in Q4 2025, an estimated $134.
Koesten Hirschmann & Crabtree first reported a position in Medtronic in Q4 2022 and held it in 12 quarters.
Koesten Hirschmann & Crabtree's Medtronic position peaked at $4.01K in Q2 2025.
2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.